Working… Menu

Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01863459
Recruitment Status : Completed
First Posted : May 29, 2013
Last Update Posted : August 2, 2017
Information provided by (Responsible Party):
Centre for Anxiety, Attention Deficit and Trauma, Ontario, Canada

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2017
Actual Study Completion Date : March 2017